Biofil Chemicals Board Meeting on Aug 11 to Approve Q1 Un-Audited Results

Biofil Chemicals & Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 11, 2026, to consider and approve the Un-Audited Financial Results for the first quarter ended June 30, 2026, along with the Limited Review Report. The meeting will also address other routine matters. Following the declaration of results, the trading window for dealing in the company's securities will reopen 48 hours after the results are announced, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company is submitting this information in both XBRL and PDF formats.